We previously showed that overexpression of CYP46A1 by intracerebral delivery of an AAV vector using CMV/β-actin hybrid promoter (CAG) promotes beneficial and neuroprotective effects in the R6/2 and zQ175 mouse models of HD [36, 37]. Here, CYP46A1 is linked to Huntington disease.